NASDAQ:OPRX - Nasdaq - US68401U2042 - Common Stock - Currency: USD
5.78
-0.41 (-6.62%)
The current stock price of OPRX is 5.78 USD. In the past month the price increased by 7.04%. In the past year, price decreased by -61.9%.
Symbol | Name | TA | FA | PE | Market Cap |
---|---|---|---|---|---|
VEEV | VEEVA SYSTEMS INC-CLASS A | 36.13 | 36.66B | ||
DOCS | DOXIMITY INC-CLASS A | 56.54 | 13.58B | ||
WAY | WAYSTAR HOLDING CORP | N/A | 7.26B | ||
CERT | CERTARA INC | 33.77 | 2.12B | ||
TDOC | TELADOC HEALTH INC | N/A | 1.98B | ||
GDRX | GOODRX HOLDINGS INC-CLASS A | 15.03 | 1.83B | ||
SDGR | SCHRODINGER INC | N/A | 1.65B | ||
PHR | PHREESIA INC | N/A | 1.64B | ||
EVH | EVOLENT HEALTH INC - A | 15.8 | 1.22B | ||
HSTM | HEALTHSTREAM INC | 50.58 | 999.88M | ||
LFMDP | LIFEMD INC - LFMD 8 7/8 PERP | N/A | 966.46M | ||
DH | DEFINITIVE HEALTHCARE CORP | 14.47 | 762.50M |
OptimizeRx Corp. is digital health company, engaged in the provision of digital health messaging via electronic health records, which serve as a direct channel for pharmaceutical companies to communicate with healthcare providers. The company is headquartered in Waltham, Massachusetts and currently employs 116 full-time employees. The company went IPO on 2005-05-18. The company offers diverse tech-enabled marketing solutions through its artificial intelligence (AI)-generated Dynamic Audience and Activation Platform (DAAP), which enables customers to execute traditional marketing campaigns on its digital point-of-care network, as well as dynamic marketing campaigns that optimize audiences in real time to increase the value of treatment information for healthcare professionals and patients in response to clinical care events. Its principal solutions include Audience Development, Audience Activation and Media Execution and Financial Messaging. Its Financial Messaging solutions provide prescribers visibility to branded copay offers directly within their electronic health record (EHR) systems and/or electronic prescribing (ERx) platforms.
OPTIMIZERX CORP
260 Charles Street, Suite 302
Waltham MASSACHUSETTS 48307 US
CEO: William Febbo
Employees: 136
Company Website: https://www.optimizerx.com/
Investor Relations: https://investors.optimizerx.com/
Phone: 12486516558
The current stock price of OPRX is 5.78 USD. The price decreased by -6.62% in the last trading session.
The exchange symbol of OPTIMIZERX CORP is OPRX and it is listed on the Nasdaq exchange.
OPRX stock is listed on the Nasdaq exchange.
14 analysts have analysed OPRX and the average price target is 9.84 USD. This implies a price increase of 70.17% is expected in the next year compared to the current price of 5.78. Check the OPTIMIZERX CORP stock analysts ratings, price target forecast and up-and down grades for more detailed information.
OPTIMIZERX CORP (OPRX) has a market capitalization of 106.47M USD. This makes OPRX a Micro Cap stock.
OPTIMIZERX CORP (OPRX) currently has 136 employees.
OPTIMIZERX CORP (OPRX) has a support level at 5.5 and a resistance level at 5.79. Check the full technical report for a detailed analysis of OPRX support and resistance levels.
The Revenue of OPTIMIZERX CORP (OPRX) is expected to grow by 27.91% in the next year. Check the estimates tab for more information on the OPRX EPS, Sales, EBIT and EBITDA future analyst estimates.
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
OPRX does not pay a dividend.
OPTIMIZERX CORP (OPRX) will report earnings on 2025-02-26, after the market close.
The PE ratio for OPTIMIZERX CORP (OPRX) is 19.93. This is based on the reported non-GAAP earnings per share of 0.29 and the current share price of 5.78 USD. Check the full fundamental report for a full analysis of the valuation metrics for OPRX.
The outstanding short interest for OPTIMIZERX CORP (OPRX) is 8.16% of its float. Check the ownership tab for more information on the OPRX short interest.
ChartMill assigns a technical rating of 5 / 10 to OPRX. When comparing the yearly performance of all stocks, OPRX is a bad performer in the overall market: 86.1% of all stocks are doing better.
ChartMill assigns a fundamental rating of 4 / 10 to OPRX. While OPRX seems to be doing ok healthwise, there are quite some concerns on its profitability.
Over the last trailing twelve months OPRX reported a non-GAAP Earnings per Share(EPS) of 0.29. The EPS increased by 20.83% compared to the year before.
Industry Rank | Sector Rank | ||
---|---|---|---|
PM (TTM) | N/A | ||
ROA | -14.63% | ||
ROE | -21.12% | ||
Debt/Equity | 0.29 |
ChartMill assigns a Buy % Consensus number of 81% to OPRX. The Buy consensus is the average rating of analysts ratings from 14 analysts.
For the next year, analysts expect an EPS growth of 25.97% and a revenue growth 27.91% for OPRX